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Abstract
Background: Dopamine receptors comprise two subgroups, Gs protein-coupled “D1-like” receptors (D1, D5) and Gi-
coupled “D2-like” receptors (D2, D3, D4). In airways, both dopamine D1 and D2 receptors are expressed on airway
smooth muscle and regulate airway smooth muscle force. However, functional expression of the dopamine D1
receptor has never been identified on airway epithelium. Activation of Gs-coupled receptors stimulate adenylyl cyclase
leading to cyclic AMP (cAMP) production, which is known to induce mucus overproduction through the cAMP
response element binding protein (CREB) in airway epithelial cells. We questioned whether the dopamine D1 receptor
is expressed on airway epithelium, and whether it promotes CREB phosphorylation and MUC5AC expression.
Methods: We evaluated the protein expression of the dopamine D1 receptor on native human airway epithelium and
three sources of cultured human airway epithelial cells including primary cultured airway epithelial cells, the bronchial
epithelial cell line (16HBE14o-), and the pulmonary mucoepidermoid carcinoma cell line (NCI-H292) using
immunohistochemistry and immunoblotting. To characterize the stimulation of cAMP through the dopamine D1
receptor, 16HBE14o- cells and NCI-H292 cells were treated with dopamine or the dopamine D1 receptor agonists
(SKF38393 or A68930) before cAMP measurements. The phosphorylation of CREB by A68930 in both 16HBE14o- and
NCI-H292 cells was measured by immunoblot. The effect of dopamine or A68930 on the expression of MUC5AC mRNA
and protein in NCI-H292 cells was evaluated by real-time PCR and immunofluorescence staining, respectively.
Results: The dopamine D1 receptor protein was detected in native human airway epithelium and three sources of
cultured human airway epithelial cells. Dopamine or the dopamine D1-like receptor agonists stimulated cAMP
production in 16HBE14o- cells and NCI-H292 cells, which was reversed by the selective dopamine D1-like receptor
antagonists (SCH23390 or SCH39166). A68930 significantly increased phosphorylation of CREB in both 16HBE14o- and
NCI-H292 cells, which was attenuated by the inhibitors of PKA (H89) and MEK (U0126). Expression of MUC5AC mRNA
and protein were also increased by either dopamine or A68930 in NCI-H292 cells.
Conclusions: These results suggest that the activation of the dopamine D1 receptor on human airway epithelium
could induce mucus overproduction, which could worsen airway obstructive symptoms.
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Background
Dopamine is a predominant catecholamine neurotrans-
mitter in the mammalian central nervous system [1–4]
but it also plays a role in modulating peripheral physio-
logic actions such as renal and cardiovascular functions
through specific dopamine receptor subtypes expressed
in peripheral organs and tissues [3, 5–8]. The dopamine
receptors belong to the superfamily of G protein-
coupled receptors (GPCR), and five different receptor
subtypes (D1-D5) have been divided into two subgroups,
the Gs protein-coupled “D1-like” receptors (D1, D5 sub-
types) and the Gi-coupled “D2-like” receptors (D2, D3,
D4 subtypes) [3, 9]. Dopamine, by acting on the dopa-
mine D1-like receptor, stimulates adenylyl cyclase activ-
ity to increase intracellular cyclic AMP (cAMP) levels
[10], which stimulate cAMP-dependent protein kinase
(PKA) [11]. PKA phosphorylates a range of target
proteins including the cAMP response element binding
protein (CREB) [12–14].
In airways, dopamine is localized in the lung [15], and
acts as a neurotransmitter in addition to its role as a
noradrenaline precursor [16]. Dopamine D1 and D2 re-
ceptors are expressed on lung alveolar type I cells, which
line most of the alveolar surface, and contribute to lung
fluid homeostasis [17]. In addition, either inhaled or
intravenously administered dopamine has bronchodila-
tory effects in human healthy and asthmatic subjects
[18]. We have previously shown that dopamine D1 and
D2 receptors are expressed on airway smooth muscle it-
self, and that the dopamine D1 receptor modulates air-
way smooth muscle tone through adenylyl cyclase/
cAMP production [19, 20], which would favor airway re-
laxation in asthmatics. Although, the dopamine D2 re-
ceptor was not detected on airway epithelial tissue [19],
the functional expression of the dopamine D1-like recep-
tor on airway epithelium remains poorly characterized.
In respiratory diseases including asthma, COPD, and
cystic fibrosis, mucus hypersecretion is a recognized
component of the pathophysiology. Airway epithelium is
the predominant source of mucus, which contributes to
airway narrowing and obstruction. MUC5AC, which is
induced by phosphorylation of CREB [21, 22], is pre-
dominantly expressed in respiratory epithelium and con-
stitutes 95–98% of the mucin secreted in the human
airway [23]. Interestingly, the dopamine D1-like receptor
agonist SKF83959 significantly exacerbated bronchial
mucus production in ovalbumin-sensitized mice [24],
which would in theory, therapeutically contrast with its
direct relaxation of airway smooth muscle [20]. Similar
contrasting findings have been reported with Gs-coupled
β2-aderenoceptor agonists, which are widely used as
bronchodilators, but have been reported to increase
mucin production via activation of β2-aderenoceptors on
airway epithelial cells [25]. These findings led us to
hypothesize that functional dopamine D1-like receptors
are expressed on airway epithelium and promote mucus
production through cellular cAMP’s activation of the
PKA-CREB-MUC5AC axis.
In the present study, protein expression of the dopa-
mine D1-like receptor was examined in native human
airway epithelial tissue and cultured human airway
epithelial cells. In addition, effects of the dopamine D1
receptor on cAMP production, CREB phosphorylation,
and MUC5AC expression were assessed to confirm their
physiological role in airway epithelium.
Methods
Materials
Protease inhibitor cocktail III was purchased from EMD
Millipore (Billerica, MA). Antibiotic-antimycotic mix,
DMEM/F-12 medium, fetal bovine serum (FBS), and
RPMI-1640 medium were purchased from Thermo Fisher
Scientific (Waltham, MA). A68930 and SCH39166 were
purchased from Tocris Bioscience (Bristol, UK). All other
chemicals were obtained from Sigma-Aldrich (St. Louis,
MO) unless otherwise stated.
Cell culture
Primary cultured normal human bronchial epithelial
cells (CC-2541; Lonza, Walkersville, MD) were grown in
Clonetics™ BEGM BulletKit (CC-3170, Lonza) supple-
mented with the following growth supplements: bovine
pituitary extract, hydrocortisone, human epidermal
growth factor, epinephrine, transferrin, insulin, retinoic
acid, triiodothyronine, and gentamicin/amphotericin-B
at the concentrations recommended by the manufac-
turer. 16HBE14o- cells, a human bronchial epithelial cell
line which was kindly gifted from Dr. Tilla S. Worgall
(Columbia University, New York NY), were grown in
minimal essential medium supplemented with 10% FBS
and 200 μg/ml geneticin (G418). NCI-H292 cells (CRL-
1848; American Type Culture Collection, Manassas, VA)
, a human pulmonary muco-epidermoid carcinoma cell
line, were cultured in RPMI-1640 medium containing
5% FBS. Primary cultured human airway smooth muscle
cells (HASM; cc-2576, Lonza) were grown in DMEM/
F12 culture medium, supplemented with 10% FBS and
an antibiotic-antimycotic mix (100 units/ml penicillin G
sodium, 100 μg/ml streptomycin sulfate, 0.25 μg/ml
amphotericin B). All the cells were incubated at 37°C in
humidified 95% air/5% CO2.
Preparation of human trachea
Studies were approved by Columbia University’s Institu-
tional Review Board (IRB) and deemed not human sub-
jects research under 45 CFR 46. Human trachea was
obtained from discarded regions of healthy donor lungs
harvested for lung transplantation at Columbia University.
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Human tissue was transported to the laboratory in cold
(4 °C) M199 cell culture media. The exterior of human
trachea was carefully dissected free of adherent connective
tissue under a microscope. The tissue sample was used for
immunohistochemistry and immunoblot.
Immunohistochemistry
Human tracheal rings were fixed with 4% paraformalde-
hyde/1% glutaraldehyde in 0.1 M phosphate buffer for
4 h at 4°C and were then dehydrated through a graded
ethanol series. The tracheal rings were embedded in par-
affin and cut into 10-μm-thick sections. The tracheal
ring sections were deparaffinized in xylene and rehy-
drated in descending grades of alcohol. Heat-mediated
antigen retrieval was performed in Tris-EDTA buffer
(10 mM Tris-base and 1 mM EDTA, pH 9.0) for 2 min
using a pressure cooker. Endogenous peroxidase activity
was blocked with 3% H2O2 for 15 min. Sections were
blocked with 10% normal goat serum in phosphate-
buffered saline with 0.1% Triton X-100 (PBST) for
30 min, then avidin-biotin blocking was performed as
previously described [26]. The slides were kept in hu-
midified chamber with primary antibody against the
dopamine D1 receptor protein (rabbit monoclonal 1:
2000; 2192–1, Epitomics, Burlingame, CA) or dopamine
D5 receptor protein (rabbit polyclonal 1:2000; sc-25,650,
Santa Cruz Biotechnology, Santa Cruz, CA) in 2% nor-
mal goat serum in PBST for overnight at 4 °C. The im-
munoreactivity of these antibodies directed against the
dopamine D1 or D5 proteins were previously confirmed
in control tissues during immunohistochemistry [20]. A
parallel tracheal ring section was incubated with an
isotype-specific rabbit IgG antibody (Thermo Fisher Sci-
entific) as a negative control. The slides were then
washed three times with PBST and primary antibodies
were detected using biotinylated anti-rabbit antibodies
(Vector Laboratories, Burlingame, CA) at a concentra-
tion of 1:200. After incubation with ABC-HRP complex
(Vector Laboratories) for 30 min, the antigen-antibody
complex was visualized with the peroxidase substrate kit
(DAB) (SK-4100, Vector Laboratories). The sections
were counterstained with hematoxylin (Vector Labora-
tories), dried, dehydrated in ascending grades of alcohol,
and cover slipped using Poly-mount mounting medium
(Polysciences, Warrington, PA).
Immunoblot analysis
Freshly dissected native human airway epithelium was
homogenized (Tekmar Ultra Turrax T25 high-speed
homogenizer set at top speed for 30 s) in cold (4°C) buf-
fer (50 mM Tris, 10 mM HEPES, pH 7.4, 1 mM EDTA
with a 1:200 dilution of protease inhibitor cocktail III).
The homogenate was filtered through 125-μm Nitex
mesh and centrifuged twice at 500 g for 15 min. The
supernatant was transferred into new tubes and centri-
fuged at 50,000 g for 30 min at 4°C. The final membrane
pellet was resuspended in the same buffer for protein
concentration determinations and stored at − 80°C.
For analysis of dopamine D1 receptor expression, con-
fluent cultures of either primary cultured normal human
bronchial epithelial cells, 16HBE14o- cells, NCI-H292
cells, or primary cultured human airway smooth muscle
cells were rinsed with ice-cold phosphate-buffered saline
(PBS), and mechanically scraped from the surface of the
T75 culture flask in the presence of protease inhibitor
cocktail III. Cells were pelleted (500 g, 10 min, 4 °C) and
lysed in ice-cold lysis buffer [20 mM Tris-HCl, pH 7.5,
150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Non-
idet P-40, 1% sodium deoxycholate, 2.5 mM sodium
pyrophosphate, 1 mM β-glycerophosphate, 1 mM
Na3VO4, 1 μg/ml leupeptin, 1 mM phenylmethanesulfo-
nyl fluoride, 1:200 dilution of protease inhibitor cocktail
III]. Lysed cells were centrifuged (15,000 g, 15 min, 4 °C)
and an aliquot of the supernatant was subjected to pro-
tein analysis and storing at − 80 °C. For analysis of CREB
phosphorylation, 16HBE14o- cells or NCI-H292 cells
were serum-starved for 24 h, and then treated with
dopamine D1 receptor agonist A68930 (1 μM) for indi-
cated times (5–60 min). In separate experiments, NCI-
H292 cells were initially pretreated with 10 μM H89
(PKA inhibitor; 30 min) or 5 μM U0126 (MEK inhibitor;
120 min) before treatment of the cells with A68930
(1 μM; 20 min). After treatment, the cells were washed
twice with ice-cold PBS, and lysed in ice-cold RIPA buf-
fer (Cell signaling Technology (CST), Danvers, MA)
supplemented with 1 mM phenylmethanesulfonyl fluor-
ide and a 1:200 dilution of protease inhibitor cocktail III.
Each lysed cell sample was harvested and centrifuged at
15000 g for 15 min at 4 °C, and an aliquot of the super-
natant was subjected to protein analysis. The protein
concentration of each sample was determined using
Pierce BCA reagents (Thermo Fisher Scientific), using
BSA as a control, and samples were stored at − 80 °C.
Each sample was solubilized by heating at 95 °C for
10 min in sample buffer (final concentrations: 50 mM
Tris HCl pH 6.8, 2.5% SDS, 6% glycerol, 2.5% 2-
mercaptoethanol, and bromophenol blue) before use. Ly-
sates were electrophoresed (10% Mini-Protean TGX™
precast gel; Bio-Rad, Hercules, CA) and transferred to
PVDF membranes using a Trans-Blot Turbo™ transfer
system (Bio-Rad). The PVDF membrane was blocked for
1 h at room temperature with 5% membrane blocking
agent (RPN418; GE Healthcare, Waukesha, WI) in Tris-
buffered saline with 0.1% Tween 20 (TBST). Membranes
were then probed with antibodies directed against the
dopamine D1 receptor protein (rabbit monoclonal 1:
1000; 2192–1, Epitomics) or the dopamine D5 receptor
protein (rabbit polyclonal 1:500; sc-25,650, Santa Cruz
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Biotechnology) overnight at 4 °C. For the CREB phos-
phorylation study, the membranes were probed with
antibodies directed against the anti-phospho CREB
(rabbit monoclonal 1:1000; CST #9198), or anti-CREB
(rabbit monoclonal 1:1000; CST #9197) overnight at 4 °
C. After washing three times with TBST, membranes
were incubated for 1 h at room temperature with HRP-
labeled secondary anti-rabbit antibodies (1:5000; GE
Healthcare, NA934V). The signals from the immunoreac-
tive bands were detected by ECL Prime (GE Healthcare)
and the signal was captured using a chemiluminescent
image analyzer (LAS 4000 Mini; GE Healthcare). The
same PVDF membranes were stripped and reprobed with
the antibody against the GAPDH protein (rabbit monoclo-
nal 1:2000, CST #5174) to demonstrate the variation in
protein loading on the gels. For analysis of CREB phos-
phorylation, the band intensities were measured using
Image J software (NIH) and were expressed as a ratio of
the phosphorylated/total CREB protein.
cAMP assays
Cyclic AMP (cAMP) production in 16HBE14o- and
NCI-H292 cell lines was measured using a HitHunter™
cAMP Assay for Small Molecules kit (DiscoverX, Fre-
mont, CA) according to the manufacturer’s instructions.
Briefly, the cells grown in white-walled 96-well plates
and were washed twice with warm PBS (37 °C). The cells
were incubated with dopamine (1 μM), or the dopamine
D1-like receptor agonists (A68930 or SKF38393) (1 μM)
for 20 min at 37 °C. The concentration and duration of
the dopamine D1-like receptor agonists used in this
study was determined based on previous studies [20,
27]. In separate experiments, the cells were pretreated
with the dopamine D1-like receptor antagonists
[SCH23390 (1 μM) or SCH39166 (1 μM)] or vehicle
(PBS) for 30 min followed by incubation with A68930
(1 μM) for 20 min at 37 °C. Then the cAMP antibody
reagent followed by the cAMP working solution (mix-
ture of enzyme donor/lysis buffer/Emerald II/Galacton)
was added to each well and incubated for 60 min at
room temperature. Cells were further incubated with the
enzyme acceptor reagent for 3 h at room temperature,
and luminescence signals were detected using a multi-
mode microplate reader (Appliskan, Thermo Fisher Sci-
entific). The data from the triplicate wells were averaged
for each sample.
Preparation of cigarette smoke extract
Cigarette smoke extract (CSE) was prepared by a modifi-
cation of a previously published method [28]. Smoke of
four commercial filtered cigarettes (Marbolo Red, Philip
Morris, Richmond, VA; 1.0 mg nicotine; 12 mg Tar) was
bubbled through 50 mL of PBS using a vacuum pump.
This 100% CSE solution was adjusted to pH 7.4 and
filtered through a 0.2 μm-pore filter to remove bacteria
and large particles.
Cell viability assay
NCI-H292 cell viability after 48 h treatment with CSE
(10% or 20%) was measured using an MTT assay kit
(Cayman Chemical, Ann Arbor, MI) according to the
manufacturer’s instructions. Briefly, NCI-H292 cells
were seeded in a 96-well plate (5000 cells/well) in
RPMI-1640 medium containing 0.5% FBS for 24 h.
Then, the cells were incubated with or without CSE
(10% or 20%) for 48 h in a final volume of 100 μl/well.
Ten microliters of MTT reagent were added to each well
and the cells were re-incubated for 4 h at 37 °C in a
CO2 incubator. The medium was aspirated, and 100 μl
of the crystal dissolving solution were added to each
well. The absorbance of each sample was measured at
570 nm using a multimode microplate reader (Applis-
kan; Thermo Fisher Scientific). The results were
expressed as a percentage of surviving cells over control
(no treatment) cells.
Quantitative RT-PCR
Total RNA was extracted from cultured NCI-H292 cells
after 48 h treatment with dopamine (1 μM), A68930
(1 μM), isoproterenol (1 μM), or CSE (10%) using the
RNeasy Mini Kit (QIAGEN, Valencia, CA). Total RNA
was transcribed into cDNA using the ReverTra Ace
qPCR RT Kit (Toyobo, Osaka, Japan) in accordance with
the manufacturer’s instructions. Quantitative real-time
PCR on the CFX96 Real-Time PCR Detection System
(Bio-Rad) was performed using Thunderbird SYBR
qPCR kit (Toyobo) according to manufacturer’s instruc-
tion. Primer sequences for MUC5AC and GAPDH were
shown in Table 1. The specificity of amplification was
confirmed by melting curve analysis. The Ct value deter-
mined by the CFX manager Software (Bio-Rad) for all
samples was normalized to the housekeeping gene
GAPDH, and the relative fold induction against un-
treated controls was computed by the comparative Ct
(ΔΔCt) method.
Table 1 Primer sequences
Target Sequence of Primer Amplicon size (bp)
Human MUC5AC FP: 5′- GGA GGA AGC TGG CCC
TGC TCT GG-3’
116
RP: 5′- AGA GAG GGC AGG GTG
GTG CTT GT-3’
Human GAPDH FP: 5′- CCA GGG CTG CTT TTA
ACT CTG GTA AAG TGG ATA-3’
173
RP: 5′- CAT CGC CCC ACT TGA
TTT TGG AGG GA −3’
FP forward primer, RP reverse primer
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Immunofluorescence staining
Immunofluorescence staining of MUC5AC protein in
NCI-H292 cells was carried out according to the previ-
ously described method [29] with some modifications.
Briefly, NCI-H292 cells were seeded on an 8-chamber
microscope slide and serum-starved for 24 h. After star-
vation, cells were exposed to A68930 (1 μM), dopamine
(1 μM), or CSE (10%) for 48 h. Cells were fixed with 4%
paraformaldehyde for 15 min at room temperature and
washed 3 times with PBS. After permeabilization (0.2%
Triton X-100 in PBS for 5 min) and blocking (1% bovine
serum albumin in 0.1% Triton X-100 in PBS for 15 min),
cells were incubated with Alexa Fluor 488-conjugated
MUC5AC antibody (sc-21,701 AF488, Santa Cruz Bio-
technology) overnight at 4C. After cells were washed
twice with PBS, the slide was coverslipped with ProLong
gold antifade-reagent with DAPI (Thermo Fisher Scien-
tific), and visualized with an inverted fluorescent micro-
scope (DMI-4000; Leica Microsystems, Wetzlar,
Germany). Digitized images were captured with Meta-
Morph software (Molecular Devices, Sunnyvale, CA).
When capturing the images, we kept constant the dur-
ation of image capture (300 ms), the image intensity
gain, the image enhancement, and the image black level
among the samples.
Statistical analysis
The data were analyzed with two-tailed paired Student’s
t-test when comparing means between two groups or re-
peated measures of ANOVA followed by Bonferroni post
test when comparing multiple groups using GraphPad
Prism 6 for Mac OS X software (GraphPad Software, La
Jolla, CA). Data are presented as mean ± SEM; P < 0.05
was considered significant.
Results
Immunohistochemical detection of dopamine D1-like
receptor expression in human tracheal epithelium
Initially, we examined the protein expression of the
dopamine D1 and D5 receptor in human tracheal epithe-
lium by immunohistochemistry. Light microscopic im-
munohistochemical staining for the dopamine D1
receptor was observed throughout the epithelial layer of
human trachea (indicated by brown color) (Fig. 1a). In
contrast, no staining of the dopamine D5 receptor was
detected in the airway epithelial layer (Fig. 1c). Consecu-
tive sections exposed to rabbit IgG isotype-specific con-
trol antibodies yielded no staining (Fig. 1b and d).
Immunoblot analysis of the dopamine D1 receptor in
human airway epithelium
We further examined whether the dopamine D1 receptor
protein was expressed in human airway epithelial tissue
and cells by immunoblot. A single immunoreactive band
of the appropriate molecular mass for the dopamine D1
receptor (75 kDa) was identified in freshly dissected hu-
man tracheal epithelium, human pulmonary muco-
epidermoid carcinoma cells (NCI-H292 cells), human
bronchial epithelial cells (16HBE14o- cells), primary cul-
tured human bronchial epithelial cells, and primary
Fig. 1 Immunohistochemical detection of dopamine D1-like receptor expression in human tracheal epithelium. a and c Representative
immunohistochemical staining of dopamine D1 receptor (a) and dopamine D5 receptor (c) in paraformaldehyde/glutaraldehyde-fixed human tracheal
epithelium. b and d anti-rabbit IgG isotype negative control in serial section of human tracheal epithelium. All sections were counterstained with hematoxylin.
Calibration bars: 50 μm. Epi, airway epithelium. Images are representative of at least 3 independent immunohistochemical analyses from human trachea
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cultured human airway smooth muscle cells (positive
control) (Fig. 2). These results suggest that the dopamine
D1 receptor is expressed on human airway epithelium of
both trachea and bronchi as well as human airway
smooth muscle.
Dopamine D1 receptor agonist-induced cAMP activity in
16HBE14o- cells and NCI-H292 cells
The dopamine D1 receptor induces production of cAMP
through the stimulation of adenylyl cyclase, which is ac-
tivated by the Gs protein [30]. Therefore, we examined
whether activation of the dopamine D1 receptor in-
creases intracellular cAMP levels in human airway epi-
thelial cells (16HBE14o- cells and NCI-H292 cells).
Dopamine (1 μM) as well as dopamine D1-like receptor
agonists (SKF38393 or A68930; 1 μM) significantly in-
creased intracellular cAMP levels in 16HBE14o- cells
(dopamine; P < 0.001, SKF38393; P < 0.001, A68930; P <
0.01, n = 6) and NCI-H292 cells (dopamine; P < 0.01,
SKF38393; P < 0.01, A68930; P < 0.01, n = 6) (Fig. 3a).
Cyclic AMP production induced by A68930 (1 μM) was
significantly reversed by pretreatment with the dopa-
mine D1 receptor antagonists SCH23390 (1 μM)
(16HBE14o- cells: P < 0.001, n = 6; NCI-H292 cells: P
< 0.05, n = 6) or SCH39166 (1 μM) (16HBE14o- cells: P
< 0.001, n = 6; NCI-H292 cells: P < 0.05, n = 6) (Fig. 3b).
Dopamine D1 receptor agonist-induced CREB
phosphorylation in 16HBE14o- cells and NCI-H292 cells
The increase of cAMP after dopamine D1 receptor acti-
vation induces the activation of protein kinase A (PKA),
which induces phosphorylation of CREB [14]. MEK-ERK
signaling also contributes to CREB phosphorylation [13].
In addition, the dopamine D1 receptor activates MEK-
ERK signaling through β-arrestin [31]. Therefore, we ex-
amined whether the dopamine D1 receptor agonist
A68930 phosphorylates CREB through PKA and/or
MEK in 16HBE14o- cells and NCI-H292 cells. A68930
(1 μM, 20 min) significantly increased phosphorylation
of CREB in 16HBE14o- cells (P < 0.05, n = 3) and NCI-
H292 cells (P < 0.05, n = 7) (Fig. 4a and b). The phos-
phorylation reached maximal levels at 20–30 min and
then slowly declined to basal levels within 60 min in
16HBE14o- cells, while the increased phosphorylation
was maintained at 60 min in NCI-H292 cells. To con-
firm that A68930 phosphorylates CREB through PKA or
MEK, NCI-H292 cells were pretreated with the PKA in-
hibitor H89 (10 μM; 30 min) or the MEK inhibitor
U0126 (5 μM; 120 min). A68930 (1 μM; 20 min)-stimu-
lated CREB phosphorylation in NCI-H292 cells was sig-
nificantly inhibited by H89 (P < 0.001, n = 4) or U0126
(P < 0.05, n = 4) (Fig. 4c). These results confirm that the
dopamine D1 receptor agonist-induced phosphorylation
of CREB proceeds through both PKA and MEK/ERK
signaling.
Dopamine D1 receptor agonist-induced MUC5AC mRNA
expression in NCI-H292 cells
CREB was previously shown to mediate the transcrip-
tional regulation of MUC5AC in airway epithelial cells
including NCI-H292 cells [21, 22, 32]. We examined
whether dopamine or the dopamine D1 receptor agonist
A68930 induces MUC5AC mRNA expression in NCI-
H292 cells. Dopamine (1 μM), A68930 (1 μM), and
Fig. 2 Representative immunoblot analyses using antibodies against the dopamine D1 receptor using total protein prepared from freshly
dissected native human tracheal epithelium (20 μg), primary cultured human airway epithelial cells (100 μg), the human bronchial epithelial cell
line (16HBE14o-) (100 μg), the human pulmonary mucoepidermoid carcinoma cell line (NCI-H292) (100 μg), and human airway smooth muscle
cells (positive control) (100 μg). Reprobing of blots for GAPDH was performed to demonstrate relative lane loading. Each image is representative
of at least 3 independent immunoblots
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cigarette smoke extract (CSE) (10%) significantly in-
creased MUC5AC mRNA expression in NCI-H292 cells.
The Gs protein-coupled β2 aderenoceptor agonist iso-
proterenol (1 μM) also significantly induced MUC5AC
mRNA expression (Fig. 5a). Previous studies in airway
epithelial cells have employed final CSE concentrations
ranging from 1 to 30% [33, 34]. MTT cell viability ana-
lyses confirmed that 48 h treatment of NCI-H292 cells
with 10% CSE or even higher concentrations (20%) of
CSE did not reduce NCI-H292 cell viability, suggesting
that treatment with CSE at 10% or 20% has no cytotox-
icity (Fig. 5b).
Dopamine D1 receptor agonist-induced MUC5AC protein
expression in NCI-H292 cells
We further investigated the effect of the dopamine D1 re-
ceptor agonist A68930 or dopamine on MUC5AC protein
expression using an immunofluorescent assay. Consistent
with the mRNA data of MUC5AC, MUC5AC protein ex-
pression in NCI-H292 cells were increased by dopamine
(1 μM), A68930 (1 μM), and CSE (10%) (Fig. 6). These re-
sults suggest that activation of dopamine D1 receptor
stimulates MUC5AC expression.
Discussion
The primary findings of the present study are that func-
tional dopamine D1 receptors are expressed in human
airway epithelium. Activation of the dopamine D1 recep-
tor stimulated cAMP production, CREB phosphoryl-
ation, and mRNA and protein expression of MUC5AC
in human airway epithelial cells.
In airways, we have previously reported that both
dopamine D1 and D2 receptors are expressed on airway
smooth muscle itself, and regulate airway smooth
muscle force [19, 20]. In the present study, protein ex-
pression of the dopamine D1 receptor on human airway
epithelium was identified by immunohistochemistry,
while the dopamine D5 receptor protein was not de-
tected. Immunoblot analyses further confirmed that the
dopamine D1 receptor is expressed in freshly dissected
native human tracheal epithelium, primary cultured hu-
man bronchial epithelial cells and cell lines derived from
airway epithelium (16HBE14o- cells and NCI-H292
cells). Since the dopamine D2 receptor was not
expressed on airway epithelium [19], the dopamine D1
receptor would be the predominant dopamine receptor
subtype expressed on human airway epithelium.
Thereafter, we further investigated whether functional
dopamine D1 receptors could modulate airway epithelial
function. The activation of Gs-coupled receptors includ-
ing the dopamine D1 receptor and β2-adrenoceptor stim-
ulates cAMP accumulation via activation of adenylyl
cyclase [3, 35, 36]. In accordance with these previous
findings, we demonstrated that dopamine or the
Fig. 3 a The effects of dopamine (1 μM) or the dopamine D1 receptor agonists (A68930 or SKF38393; 1 μM respectively) on cAMP production in
cultured (i) 16HBE14o- cells and (ii) NCI-H292 cells. n = 6. b The effect of dopamine D1-like receptor selective antagonists SCH23390 or SCH39166
on A68930-stimulated cAMP production in cultured (i) 16HBE14o- cells and (ii) NCI-H292 cells. Cells were pretreated with SCH23390 (1 μM) or
SCH39166 (1 μM) for 30 min prior to A68930 (1 μM) treatment for 20 min. n = 6. Data represent means ± SEM. **P < 0.01 and ***P < 0.001
compared with basal. #P < 0.05 and ###P < 0.001 compared with A68930 alone
Matsuyama et al. Respiratory Research  (2018) 19:53 Page 7 of 11
dopamine D1 receptor agonists (SKF38393 or A68930)
stimulated cAMP production in 2 different cell lines of
human airway epithelial cells (16HBE14o- cells and
NCI-H292 cells), which was significantly reversed by
pretreatment the cells with the dopamine D1-like recep-
tor antagonists (SCH23390 or SCH39166). These find-
ings suggest that stimulation of the dopamine D1
receptor on human airway epithelial cells induces intra-
cellular cAMP accumulation.
A major signaling target of cAMP is PKA, which can
translocate to the nucleus and subsequently phosphoryl-
ate CREB. The present study demonstrated that the
dopamine D1 receptor agonist A68930 induced phos-
phorylation of CREB in 16HBE14o- cells and NCI-H292
cells. This phosphorylation reached maximum levels at
20–30 min which is consistent with our findings that
A68930 significantly induced cAMP accumulation at
20 min in 16HBE14o- cells and NCI-H292 cells. Fur-
thermore, A68930-induced CREB phosphorylation was
blocked by the PKA inhibitor H89, suggesting that acti-
vation of the dopamine D1 receptor induces CREB phos-
phorylation through classical cAMP-PKA signaling.
Other principal signaling cascades responsible for CREB
phosphorylation include the MEK-ERK pathway [13].
Fig. 4 Effects of the dopamine D1 receptor agonist A68930 on the phosphorylation of CREB in cultured airway epithelial cells. Cells were
stimulated with A68930 (1 μM), and subsequently cell lysates were processed to detect phosphorylated (upper panels) and total (lower panels)
levels of CREB by immunoblot. a Representative immunoblot analyses of the time-course effect of the dopamine D1 receptor agonist A68930
(1 μM) on CREB phosphorylation in cultured (i) 16HBE14o- cells and (ii) NCI-H292 cells. Phosphorylated activating transcription factor 1 (ATF-1) is a
CREB family member that is also recognized by the phospho-CREB antibody and closely correlates with CREB [13]. b Effect of A68930 (1 μM,
20 min) on CREB phosphorylation in (i) 16HBE14o- cells (n = 3) and (ii) NCI-H292 cells (n = 7). c Effects of inhibitors of PKA or MEK on A68930-
stimulated CREB phosphorylation in NCI-H292 cells (n = 4). Cells were pretreated with the PKA inhibitor H89 (10 μM, 30 min), or the MEK inhibitor
U0126 (5 μM, 120 min) before treatment with A68930 (1 μM, 20 min). Data represent means ± SEM. *P < 0.05 compared with basal. #P < 0.05 and
###P < 0.001 compared with A68930 alone
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Previous studies suggested that the dopamine D1 recep-
tor activates MEK-ERK signaling through β-arrestin [31].
In the present study, the MEK inhibitor U0126 signifi-
cantly inhibited dopamine D1 receptor-mediated CREB
phosphorylation. Collectively, activation of dopamine D1
receptor induces CREB phosphorylation through both
cAMP/PKA and MEK/ERK signaling.
CREB increases the transcription of MUC5AC in NCI-
H292 cells [21]. Our findings demonstrated that dopa-
mine or the dopamine D1 receptor agonist A68930 in-
duced expression of MUC5AC mRNA and MUC5AC
protein, the most prominent mucin in airways. These re-
sults were consistent with the previous findings from
Gong et al. [24] that the dopamine D1-like receptor
agonist SKF83959 significantly exacerbated bronchial
mucus production. They also showed that the dopamine
D1-like receptor antagonist SCH23390 attenuated mucus
production in the ovalbumin-sensitized mice, although
they speculated that attenuated mucus production after
blockade of dopamine D1-like receptor signaling by
SCH23390 was predominantly mediated by decreased
IL-17 secretion. In contrast, our results suggest that Gs-
coupled dopamine D1 receptor signaling could contrib-
ute to MUC5AC expression through cAMP/CREB
pathways without involving inflammatory mediators.
Although activation of the dopamine D1 receptor
expressed on airway smooth muscle induced airway re-
laxation [20], the present study suggests that activation
of the dopamine D1 receptor on airway epithelium could
worsen asthma symptoms by mucus overproduction.
These paradoxical effects of dopamine D1 receptor acti-
vation on airways would hamper the clinical use of a
dopamine D1 receptor agonist as a novel treatment op-
tion of asthma and COPD. Similar paradoxical findings
have been reported in other Gs-coupled receptor (e.g.
Fig. 5 a Effect of dopamine D1 receptor agonists on MUC5AC mRNA
expression in NCI-H292 cells. The cells were treated for 48 h with
dopamine (1 μM), the dopamine D1 receptor agonist A68930 (1 μM),
the Gs protein-coupled β2 adrenoceptor agonist isoproterenol (ISO;
1 μM), or cigarette smoke extract (CSE; 10%: positive control). Data
represent means ± SEM. *P < 0.05, **P < 0.01 compared with basal.
n = 14. b NCI-H292 cell viability analysis with MTT assay after 48 h
treatment with CSE (10 or 20%); n = 13. Data are shown as
percentages of absorbance at 570 nm compared with no treatment
control and represent means ± SEM. n.s. compared with no
treatment control
Fig. 6 Representative images of immunofluorescent staining of NCI-H292 cells with an Alexa Fluor 488-conjugated mouse monoclonal antibody
against human MUC5AC (green). Cells were incubated in the presence or absence of the dopamine D1 receptor agonist A68930 (1 μM), dopamine
(1 μM), or CSE (10%: positive control) for 48 h before staining. Nuclei were stained with DAPI (blue). Images are representative of 3 independent
immunofluorescence stainings
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β2-aderenoceptor) in airways. Although activation of β2-
aderenoceptor on airway smooth muscle induces bron-
chodilation, β2-adrenoceptor on airway epithelial cells
increase mucus production, which exacerbates the
symptoms of asthma and COPD [25, 37]. In contrast, it
is well established that cAMP stimulates cilliary motility
of airway epithelium [38–40]. These findings point out
the possibility that activation of the dopamine D1 recep-
tor on airway epithelium might enhance mucociliary
clearance, which is beneficial for asthma and COPD pa-
tients with impaired airway mucociliary clearance. More-
over, elevation of cAMP levels and activation of PKA
through Gs-coupled receptor also contributes to bron-
chial epithelial wound repair and regulation of cystic fi-
brosis transmembrane regulator (CFTR) activity in
airway epithelium [41–43]. Thus, activation of the dopa-
mine D1 receptor on multiple cell types in the airway
could affect multiple beneficial and potentially detrimen-
tal airway effects and it is unclear what the net effect
would be in the setting of allergic lung inflammation and
bronchoconstriction. A limitation of the present study is
that we have used submerged NCI-H292 cells to examine
dopamine D1 receptor-mediated MUC5AC expression.
Submerged cells in culture may not recapitulate the
phenotype of in vivo airway epithelium as closely as pri-
mary cultured bronchial epithelial cells grown at an air-
liquid interface. Further studies are required to identify
the possible diverse roles of dopamine D1 receptor in the
normal physiology and pathophysiology of the airway.
Conclusions
In summary, our major findings in this study are that Gs-
coupled dopamine D1 receptors are expressed in human
airway epithelium, and stimulate cAMP production, CREB
phosphorylation, and MUC5AC expression. These results
combined with our previous findings [20], suggest that ac-
tivation of the dopamine D1 receptor in airways can have
complex net effects from the activation of the dopamine
D1 receptor on multiple cell types. While activation of the
dopamine D1 receptor on airway smooth muscle could
have a bronchodilatory therapeutic benefit, the activation
of the dopamine D1 receptor on airway epithelium could
induce mucus overproduction which may be counteracted
by a beneficial effect on ciliary activity.
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